πŸ‡ΊπŸ‡Έ FDA
Patent

US 7786083

Metastin derivatives and use thereof

granted A61KA61K38/00A61P

Quick answer

US patent 7786083 (Metastin derivatives and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/02